Department of Radiology & Nuclear Medicine, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, P.O. Box 7057, 1007 MB, Amsterdam, The Netherlands.
Amsterdam Neuroscience, Neurodegeneration, Amsterdam, The Netherlands.
Eur J Nucl Med Mol Imaging. 2023 Jul;50(8):2409-2419. doi: 10.1007/s00259-023-06196-2. Epub 2023 Mar 28.
Tau pathology is associated with concurrent atrophy and decreased cerebral blood flow (CBF) in Alzheimer's disease (AD), but less is known about their temporal relationships. Our aim was therefore to investigate the association of concurrent and longitudinal tau PET with longitudinal changes in atrophy and relative CBF.
We included 61 individuals from the Amsterdam Dementia Cohort (mean age 65.1 ± 7.5 years, 44% female, 57% amyloid-β positive [Aβ +], 26 cognitively impaired [CI]) who underwent dynamic [F]flortaucipir PET and structural MRI at baseline and 25 ± 5 months follow-up. In addition, we included 86 individuals (68 CI) who only underwent baseline dynamic [F]flortaucipir PET and MRI scans to increase power in our statistical models. We obtained [F]flortaucipir PET binding potential (BP) and R values reflecting tau load and relative CBF, respectively, and computed cortical thickness from the structural MRI scans using FreeSurfer. We assessed the regional associations between i) baseline and ii) annual change in tau PET BP in Braak I, III/IV, and V/VI regions and cortical thickness or R in cortical gray matter regions (spanning the whole brain) over time using linear mixed models with random intercepts adjusted for age, sex, time between baseline and follow-up assessments, and baseline BP in case of analyses with annual change as determinant. All analyses were performed in Aβ- cognitively normal (CN) individuals and Aβ+ (CN and CI) individuals separately.
In Aβ+ individuals, greater baseline Braak III/IV and V/VI tau PET binding was associated with faster cortical thinning in primarily frontotemporal regions. Annual changes in tau PET were not associated with cortical thinning over time in either Aβ+ or Aβ- individuals. Baseline tau PET was not associated with longitudinal changes in relative CBF, but increases in Braak III/IV tau PET over time were associated with increases in parietal relative CBF over time in Aβ + individuals.
We showed that higher tau load was related to accelerated cortical thinning, but not to decreases in relative CBF. Moreover, tau PET load at baseline was a stronger predictor of cortical thinning than change of tau PET signal.
tau 病理学与阿尔茨海默病(AD)中的并发萎缩和脑血流(CBF)减少有关,但关于它们的时间关系知之甚少。因此,我们的目的是研究并发和纵向 tau PET 与萎缩和相对 CBF 的纵向变化之间的关联。
我们纳入了来自阿姆斯特丹痴呆队列的 61 名个体(平均年龄 65.1±7.5 岁,44%为女性,57%为淀粉样蛋白-β阳性 [Aβ+],26 名认知障碍 [CI]),他们在基线和 25±5 个月随访时接受了动态 [F]flortaucipir PET 和结构 MRI 检查。此外,我们还纳入了 86 名仅在基线时接受动态 [F]flortaucipir PET 和 MRI 扫描的个体,以增加我们统计模型的效力。我们从结构 MRI 扫描中获得了 [F]flortaucipir PET 结合潜力(BP)和 R 值,分别反映 tau 负荷和相对 CBF,并使用 FreeSurfer 计算皮质厚度。我们使用线性混合模型,对 Braak I、III/IV 和 V/VI 区域中的基线和年度 tau PET BP 变化与皮质厚度或 R 值(跨越整个大脑)之间的区域关联进行评估,该模型具有随机截距,可调整年龄、性别、基线和随访评估之间的时间以及分析中年度变化作为决定因素的基线 BP。所有分析均在 Aβ-认知正常(CN)个体和 Aβ+(CN 和 CI)个体中分别进行。
在 Aβ+个体中,更高的基线 Braak III/IV 和 V/VI tau PET 结合与主要额颞叶区域的皮质变薄更快有关。在 Aβ+或 Aβ-个体中,tau PET 的年度变化与随时间推移的皮质变薄无关。基线 tau PET 与纵向相对 CBF 的变化无关,但随着时间的推移,Braak III/IV tau PET 的增加与 Aβ+个体的顶叶相对 CBF 的增加有关。
我们发现 tau 负荷越高与皮质变薄加速有关,而与相对 CBF 减少无关。此外,tau PET 负荷在基线时是皮质变薄的一个更强预测因素,而不是 tau PET 信号的变化。